{site-name}

WHY WAISMAN?

The primary mission of  Waisman Biomanufacturing is to deliver efficient translation of scientific discoveries for early stage clinical trials by developing manufacturing processes and quality control methods in conjunction with providing overall product development and regulatory support. Our goal is to accelerate the advancement of novel biological therapies and vaccines by offering the manufacturing and support services required for cGMP production of drugs used in human clinical trials. Waisman Biomanufacturing has a proven track record for producing high-quality clinical trial material for both large and small biotech companies, universities, and federal agencies such as the National Institutes of Health (NIH).

Since opening its cGMP facility in 2001, Waisman Biomanufacturing has manufactured over 320 clinical grade products and has earned a reputation for working closely with clients for cost effective and timely manufacture of quality products.  We strive to meet these high standards with each product campaign.

Read more